The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 08, 2026

Filed:

Apr. 28, 2023
Applicant:

Kimberly-clark Worldwide, Inc., Neenah, WI (US);

Inventors:

Douglas R. Hoffman, Neenah, WI (US);

Amy L. Vanden Heuvel, Neenah, WI (US);

Jeremy D. Paulsen, Neenah, WI (US);

Paige N. Anunson, Neenah, WI (US);

Lisa M. Kroll, Neenah, WI (US);

Corey T. Cunningham, Neenah, WI (US);

David W. Koenig, Neenah, WI (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61L 2/18 (2026.01); A61K 31/194 (2006.01); A61K 31/205 (2006.01); A61K 31/661 (2006.01); A61K 45/06 (2006.01); A61P 31/12 (2006.01);
U.S. Cl.
CPC ...
A61L 2/18 (2013.01); A61K 31/194 (2013.01); A61K 31/205 (2013.01); A61K 31/661 (2013.01); A61K 45/06 (2013.01); A61P 31/12 (2018.01); Y02A 50/30 (2018.01);
Abstract

A disinfectant composition that contains a unique combination of a primary antiviral agent and a secondary antiviral agent is provided. More particularly, the primary antiviral agent includes a polyprotic acid having a low first acid dissociation constant and the secondary antiviral agent is selected from the group consisting of an anionic N-acyl compound, metal halide salt, amine compound, amine compound, aliphatic amine oxide, alkyl glycoside, alcohol ethoxylate, and combinations thereof. By selectively controlling the particular nature of each antiviral agent and their relative concentration, the present inventors have discovered that a synergistic affect can be achieved in which the disinfectant composition is capable of exhibiting an antiviral efficacy against non-enveloped viruses.


Find Patent Forward Citations

Loading…